A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PUVA

Search Conditions:
Search Keyword : PUVA
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: PUVA
Appearance Frequency: 792 time(s)
Long forms: 107

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
psoralen and ultraviolet A
(171 times)
Dermatology
(126 times)
NB-UVB (20 times)
MF (17 times)
UVB (16 times)
1978 Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.
plus ultraviolet A
(123 times)
Dermatology
(101 times)
UVB (15 times)
MF (13 times)
8-MOP (11 times)
1985 Disseminated superficial actinic porokeratosis: appearance associated with photochemotherapy for psoriasis.
psoralen-UVA
(106 times)
Dermatology
(81 times)
NB-UVB (10 times)
8-MOP (7 times)
PASI (6 times)
1979 The effects of psoralen and UVA (PUVA) on epidermal melanocytes of the tail in C57BL mice.
plus UVA
(103 times)
Dermatology
(69 times)
8-MOP (13 times)
NB-UVB (11 times)
MF (10 times)
1979 Effect of 8-methoxypsoralen plus UVA (PUVA) on lymphocyte transformation and T cells in psoriatic patients.
plus long-wave ultraviolet light
(42 times)
Dermatology
(24 times)
UVA (4 times)
8-MOP (3 times)
MF (2 times)
1978 Ultrastructural changes in nuclei and nucleoli in psoriatic epidermis during and after PUVA therapy.
psoralen and ultraviolet A radiation
(37 times)
Dermatology
(11 times)
UVB (4 times)
SCC (3 times)
8-MOP (2 times)
1979 Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
plus UVA radiation
(18 times)
Dermatology
(9 times)
PUVA-SP (2 times)
8-MOP (1 time)
BMT (1 time)
1981 Differences in the immunologic reactivity of mice treated with UVB or methoxsalen plus UVA radiation.
psoralen-ultraviolet A photochemotherapy
(16 times)
Dermatology
(10 times)
UVB (4 times)
CI (2 times)
CTCL (2 times)
1988 Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis.
plus UVA light
(9 times)
Dermatology
(2 times)
8-MOP (2 times)
ICLs (2 times)
4NQO (1 time)
1981 Relationship between epidermal Langerhans cell density ATPase activity and the induction of contact hypersensitivity.
10  posterior urethrovesical angle
(8 times)
Urology
(4 times)
SUI (6 times)
ALPP (2 times)
ROC (2 times)
1999 [Usefulness of urethral descent for evaluating the type of female stress urinary incontinence].
11  psoralen and UVA radiation
(8 times)
Dermatology
(3 times)
UV (2 times)
BciVI (1 time)
CTCL (1 time)
1992 Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro.
12  plus long-wave ultraviolet radiation
(7 times)
Dermatology
(6 times)
8-MOP (1 time)
DNCB (1 time)
IL-2 (1 time)
1979 Combination therapy for psoriasis. Psoralens plus long-wave ultraviolet radiation with betamethasone valerate.
13  psoralen combined with ultraviolet A
(6 times)
Dermatology
(4 times)
ALA-PDT (1 time)
CFCL (1 time)
CR (1 time)
2013 Primary cutaneous follicular helper T-cell lymphoma: diagnostic pitfalls of this new lymphoma subtype.
14  photochemotherapy with 8-methoxypsoralen and UVA
(5 times)
Dermatology
(5 times)
DNCB (1 time)
MF (1 time)
1977 The pigmentary response to photochemotherapy.
15  psoralen and UVA light
(5 times)
Therapeutics
(2 times)
GVHD (2 times)
BMT (1 time)
CTCL (1 time)
1993 Interferon treatment of cutaneous T-cell lymphoma.
16  psoralen with long-wave UV radiation in the A range
(5 times)
Dermatology
(5 times)
LCH (1 time)
1991 Primary cutaneous Langerhans cell histiocytosis in an adult.
17  psoralens with UVA
(5 times)
Dermatology
(2 times)
BMT (1 time)
CTCL (1 time)
DMSO (1 time)
1995 Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy.
18  psoriasis treated with oral 8-methoxypsoralen and longwave ultraviolet light
(4 times)
Dermatology
(2 times)
UVA (1 time)
1977 Treatment of resistant psoriasis with oral 8-methoxypsoralen and longwave ultraviolet light (PUVA). A treatment schedule and a follow-up study.
19  Phototherapy with UVB and photochemotherapy
(3 times)
Internal Medicine
(1 time)
--- 1998 The management of psoriasis.
20  plus UV radiation at 320-400 nm
(3 times)
Neoplasms
(3 times)
--- 1984 In vivo effects of psoralens plus longwave ultraviolet radiation on immunity.
21  plus UVA therapy
(3 times)
Dermatology
(2 times)
EPR (1 time)
PEG (1 time)
RCTs (1 time)
2006 Synthesis and biological in vitro evaluation of novel PEG-psoralen conjugates.
22  psoralen-UVA photochemotherapy
(3 times)
Dermatology
(3 times)
BCC (1 time)
MC1R (1 time)
MPD (1 time)
1987 Scleromyxoedema--successful treatment with plasma exchange and immunosuppression.
23  Psoralens, together with ultraviolet light A
(3 times)
Allergy and Immunology
(2 times)
8-MOP (1 time)
DTH (1 time)
FGG (1 time)
1993 Selective inactivation of lymphocytes after psoralen/ultraviolet light (PUVA) treatment without affecting systemic immune responses.
24  Photochemotherapy with 8-methoxypsoralen and long wavelength ultraviolet radiation
(2 times)
Dermatology
(1 time)
OLP (1 time)
1995 Photochemotherapy of oral lichen planus. A controlled study.
25  Phototherapy with ultraviolet A radiation combined with 8-methoxypsoralen
(2 times)
Chemistry
(1 time)
CTCL (2 times)
ECP (2 times)
MF (2 times)
2017 Phototherapy of mycosis fungoides.
26  plus ex vivo longwave ultraviolet irradiation of the graft
(2 times)
Nephrology
(1 time)
MHC (1 time)
1989 [PUVA treatment of organ transplants--experimental and clinical results].
27  plus long wave UV light
(2 times)
Allergy and Immunology
(1 time)
--- 1984 Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis.
28  plus long-wave UV-A
(2 times)
Dermatology
(1 time)
--- 2003 Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
29  plus near-UV
(2 times)
Genetics
(1 time)
8-MOP (1 time)
ANG (1 time)
1989 Mutational specificity and the influence of excision repair: insights into the mechanisms of error-avoidance and error-fixation.
30  plus ultraviolet light therapy
(2 times)
Dermatology
(1 time)
ECP (2 times)
CTCL (1 time)
SzS (1 time)
2007 ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
31  plus UVA exposure
(2 times)
Dermatology
(1 time)
8-MOP (1 time)
MPP (1 time)
MTT (1 time)
1978 [Clinical and histological evaluation of oral psoralen plus UV-A exposure (PUVA) for treating psoriasis vulgaris (author's transl)].
32  previous exposure to oral 8-methoxypsoralen-ultraviolet-A
(2 times)
Dermatology
(2 times)
CAD (1 time)
CI (1 time)
CVD (1 time)
2013 Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion.
33  psolaren associated to UVA
(2 times)
Dermatology
(2 times)
CRP (2 times)
NB-UVB (2 times)
PASI (2 times)
2010 C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy.
34  psoralen in combination with ultraviolet-A radiation
(2 times)
Medicine
(1 time)
CM (1 time)
2008 The increase in melanoma: are dietary furocoumarins responsible?
35  psoralen with long-wave UV-A radiation
(2 times)
Dermatology
(2 times)
--- 1993 Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
36  psoralens and artificial ultraviolet A
(2 times)
Dermatology
(2 times)
--- 1987 Psoralen photochemotherapy.
37  psoralens and high-intensity long-wave ultraviolet light
(2 times)
Dermatology
(2 times)
--- 1979 Photochemotherapy for psoriasis. A clinical cooperative study of PUVA-48 and PUVA-64.
38  psoralens combined with UVA irradiation
(2 times)
Pharmacology
(1 time)
PASI (1 time)
2002 Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
39  8-methoxy-psoralen and subsequent exposures to ultraviolet A radiation
(1 time)
Allergy and Immunology
(1 time)
--- 1990 Cutaneous pigmented melanocytic tumor in a mouse treated with psoralen plus ultraviolet A radiation.
40  patient to long-wave UV-A
(1 time)
Genetics
(1 time)
8-MOP (1 time)
SCE (1 time)
1994 Mutagenic risk in psoriatic patients before and after 8-methoxypsoralen and long-wave ultraviolet radiation.
41  patients and with methoxsypsoralen followed by longwave ultraviolet light
(1 time)
Dermatology
(1 time)
--- 1980 Normalized light reactions in mycosis fungoides patients after complete remission of skin lesions.
42  patients on long-term therapy with methoxsalen and UV-A radiation
(1 time)
Dermatology
(1 time)
--- 1983 Abnormal lymphocyte function following long-term PUVA therapy for psoriasis.
43  patients treated with 8-methoxypsoralen and UVA
(1 time)
Dermatology
(1 time)
--- 1978 Psoralen/UVA treatment and chromosomes. II. Analyses of psoriasis patients.
44  patients under continued treatment with methoxsalen and long-wave ultraviolet irradiation
(1 time)
Dermatology
(1 time)
--- 1979 Amyloid deposition after psoriasis therapy with psoralen and long-wave ultraviolet light.
45  patients undergoing broad-band UVB, narrow-band UVB, or psoralen plus
(1 time)
Dermatology
(1 time)
NK (1 time)
UCA (1 time)
UV (1 time)
1993 Effect of phototherapy and urocanic acid isomers on natural killer cell function.
46  patients who developed multiple keratoacanthomas while receiving photochemotherapy
(1 time)
Dermatology
(1 time)
--- 1983 Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A photochemotherapy.
47  patients who had 8-methoxypsoralen-ultraviolet light A
(1 time)
Dermatology
(1 time)
--- 1989 A preliminary study on the link between PUVA and skin cancer.
48  penetrating longwave ultraviolet radiation
(1 time)
Biochemistry
(1 time)
--- 1986 The influence of photochemical treatment on immunogenicity and epidermal Langerhans cells of murine skin grafts.
49  performed 8-methoxypsolaren and ultraviolet A
(1 time)
Hematology
(1 time)
GVHD (1 time)
1995 [PUVA therapy for cutaneous acute graft-versus-host disease--a case report].
50  performed with standard 8-methoxypsoralen-UV-A
(1 time)
Dermatology
(1 time)
--- 1980 PUVA-treatment for solar urticaria and persistent light reaction.
51  photoactive medications taken in conjunction with oral methoxsalen photochemotherapy
(1 time)
Dermatology
(1 time)
--- 1980 Phototoxic reactions to photoactive drugs in patients treated with PUVA.
52  photocatalysis, and a second where UVA is combined with psoralens
(1 time)
Microbiology
(1 time)
PDT (1 time)
2013 Can biowarfare agents be defeated with light?
53  Photochemotherapy employing 8-methoxypsoralen and ultraviolet radiation
(1 time)
Environmental Health
(1 time)
SCC (1 time)
1998 Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks.
54  Photochemotherapy using 8-methoxypsoralen in combination with UVA radiation
(1 time)
Cell Biology
(1 time)
--- 2016 Gene expression profiling reveals the role of RIG1 like receptor signaling in p53 dependent apoptosis induced by PUVA in keratinocytes.
55  Photochemotherapy using methoxsalen in combination with long-wave ultraviolet light
(1 time)
Dermatology
(1 time)
--- 1999 PUVA therapy: current concerns in Japan.
56  Photochemotherapy with 8-methoxypsoralen and long-wavelength UV-A
(1 time)
Dermatology
(1 time)
--- 2007 [Use of psoralen plus UV-A therapy in the autonomous community of Valencia, Spain].
57  photochemotherapy with 8-methoxypsoralen followed by ultraviolet A
(1 time)
Medicine
(1 time)
MF (1 time)
2014 PUVA phototherapy-induced secondary amyloidosis in patients with mycosis fungoides: a rare adverse effect of phototherapy.
58  photochemotherapy with 8-methoxypsoralen in conjunction with high-intensity long-wave ultraviolet light
(1 time)
Dermatology
(1 time)
--- 1983 The occurrence of vitiligo after psoralens and ultraviolet a therapy.
59  photochemotherapy with 8-MOP and long-wave ultraviolet light
(1 time)
Dermatology
(1 time)
8-MOP (1 time)
HPLC (1 time)
1980 Plasma levels of 8-methoxypsoralen determined by high-pressure liquid chromatography in psoriatic patients ingesting drug from two manufacturers.
60  photochemotherapy with oral 8-MOP followed by UV-A
(1 time)
Dermatology
(1 time)
--- 1980 Therapy of psoriasis: comparison of photochemotherapy and several variants of phototherapy.
61  photochemotherapy with ultraviolet A light
(1 time)
Allergy and Immunology
(1 time)
ECP (1 time)
NP (1 time)
2010 Intranasal PUVA phototherapy in nasal polyposis--a pilot study.
62  photochemotherapy with ultraviolet-A light and psoralenes
(1 time)
Medicine
(1 time)
UVB (1 time)
2004 [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].
63  photochemotherapy with UVA
(1 time)
Dermatology
(1 time)
AD (1 time)
1993 A proposed guideline for psoralen photochemotherapy (PUVA) with atopic dermatitis: successful therapeutic effect on severe and intractable cases.
64  photosensitizer 8-methoxypsoralen and ultraviolet A radiation
(1 time)
Cell Biology
(1 time)
ICL (1 time)
2006 Senescence of human fibroblasts after psoralen photoactivation is mediated by ATR kinase and persistent DNA damage foci at telomeres.
65  photosensitizer 8-methoxypsoralen and UVA light
(1 time)
Biochemistry
(1 time)
--- 1989 Influence of a transfusion of donor leukocytes treated with 8-methoxypsoralen and long-wave ultraviolet light (PUVA) on skin allograft survival in mice.
66  photosensitizer with UVA irradiation
(1 time)
Pharmacology
(1 time)
8-MOP (1 time)
1996 Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment.
67  phototoxic reaction to 8-methoxypsoralen and long-wave ultraviolet light
(1 time)
Dermatology
(1 time)
--- 1979 Interaction of methotrexate and betamethasone with experimental phototoxic inflammation to PUVA (Psoralen and UVA) in mice.
68  plus near-UV light
(1 time)
Genetics
(1 time)
MMC (1 time)
1982 Topoisomerase involvement in multiplicity reactivation of phage T4.
69  plus noninflammatory doses of long-wave UV radiation
(1 time)
Dermatology
(1 time)
AA (1 time)
UV (1 time)
1990 Ultraviolet radiation suppresses mouse-ear edema induced by topical application of arachidonic acid.
70  plus subsequest UVA
(1 time)
Dermatology
(1 time)
--- 1999 Current consensus and update on psoriasis therapy: a perspective from the U.S.
71  plus ultraviolet A treatment
(1 time)
Dermatology
(1 time)
--- 1986 Status of ultraviolet A dosimetry in methoxsalen plus ultraviolet A therapy.
72  plus UVA phototherapy
(1 time)
Dermatology
(1 time)
NB-UVB (1 time)
2009 What is the most common phototherapy prescription for psoriasis: NB-UVB or PUVA? Prescription behavior.
73  plus UVA, i.e., 320-400 nm radiation
(1 time)
Neoplasms
(1 time)
--- 1984 Effects of methoxsalen plus near-ultraviolet radiation or mid-ultraviolet radiation on immunologic mechanisms.
74  porcine skin from UVA-mediated phototoxic reactions
(1 time)
Dermatology
(1 time)
--- 1992 Topical vitamin C protects porcine skin from ultraviolet radiation-induced damage.
75  potentially beneficial effect of 8-methoxypsoralen and ultraviolet A
(1 time)
Transplantation
(1 time)
--- 1990 8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.
76  pretumour stage were treated with oral 8-MOP and UVA photochemotherapy
(1 time)
Dermatology
(1 time)
--- 1981 Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
77  previous investigations have indicated that photochemotherapy
(1 time)
Dermatology
(1 time)
8-MOP (1 time)
1986 PUVA therapy damages psoriatic and normal lymphoid cells within milliseconds.
78  products alone or with low-dose 8-methoxypsoralen + UVA
(1 time)
Dermatology
(1 time)
EGF (1 time)
GH (1 time)
1988 Treatment of severe psoriasis with somatostatin: four years of experience.
79  prolonged exposure to UVA
(1 time)
Dermatology
(1 time)
DMSO (1 time)
1981 The proliferative and toxic effects of ultraviolet light and inflammation on epidermal pigment cells.
80  propose 5-MOP as a valuable alternative for photochemotherapy
(1 time)
Dermatology
(1 time)
5-MOP (1 time)
1988 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation.
81  prospective study on oral methoxsalen photochemotherapy
(1 time)
Dermatology
(1 time)
CTCL (1 time)
1984 Photochemotherapy for cutaneous T cell lymphoma. A follow-up study.
82  psoralen chemotherapy with ultraviolet A
(1 time)
Dermatology
(1 time)
--- 1992 Atopic dermatitis: studies of skin permeability and effectiveness of topical PUVA treatment.
83  psoralen combined with A-band ultraviolet
(1 time)
Allergy and Immunology
(1 time)
ecpDCs (1 time)
IL-4 (1 time)
imDCs (1 time)
2017 [Immature dendritic cells phagocytosing human spleen cells treated by PUVA present the characteristics of regulatory dendritic cells].
84  psoralen combined with UVA
(1 time)
Biochemistry
(1 time)
--- 2017 Phosphor for phototherapy: Review on psoriasis.
85  Psoralen in combination with ultraviolet-A
(1 time)
Biology
(1 time)
UDL (1 time)
2017 Development and in vitro assessment of psoralen and resveratrol co-loaded ultradeformable liposomes for the treatment of vitiligo.
86  Psoralen in conjunction with UVA
(1 time)
Biochemistry
(1 time)
--- 1999 Urinary thymine dimers and 8-oxo-2'-deoxyguanosine in psoriasis.
87  psoralen in connection with ultraviolet irradiation therapy
(1 time)
Drug Therapy
(1 time)
MPs (1 time)
PLGA (1 time)
2006 Characterization of PLGA microparticles as a drug carrier for 3-ethoxycarbonyl-2h-benzofuro[3,2-f]-1-benzopyran-2-one. Ultrastructural study of cellular uptake and intracellular distribution.
88  psoralen ultraviolet A-range
(1 time)
Dermatology
(1 time)
--- 2002 Phototherapy utilization for psoriasis is declining in the United States.
89  psoralen with exposure to ultraviolet A
(1 time)
Dermatology
(1 time)
--- 2003 Treatment of vitiligo: current methods and new approaches.
90  psoralen with UVA phototherapy
(1 time)
Antineoplastic Agents
(1 time)
--- 2014 Systematic review of combination therapies for mycosis fungoides.
91  Psoralen--UVA radiation treatment
(1 time)
Medicine
(1 time)
CAT (1 time)
HAART (1 time)
VL (1 time)
2010 HIV/AIDS-associated Kaposi's sarcoma with multiple skin-mucosal disseminations following ultraviolet (puva) photochemotherapy.
92  Psoralen-enhanced UVA irradiation
(1 time)
Transplantation
(1 time)
--- 2005 Novel approaches in GVHD therapy.
93  psoralens and UV radiation at 320-400 nm
(1 time)
Neoplasms
(1 time)
8-MOP (1 time)
1984 Quantitative tests for psoralens in the blood: methods and uses in monitoring psoralen and longwave radiation therapy.
94  psoralens combined with exposure to ultraviolet light
(1 time)
Pharmacy
(1 time)
--- 1989 Use of retinoids in the treatment of psoriasis.
95  psoralens in combination with UV light A
(1 time)
Neoplasms
(1 time)
CTCL (1 time)
P-gp (1 time)
2000 P-glycoprotein expression and multidrug resistance in cutaneous T-cell lymphoma.
96  psoralens with longwave ultraviolet radiation in the A range
(1 time)
Drug Therapy
(1 time)
--- 1999 Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
97  psoralen + UVA-treated
(1 time)
Medicine
(1 time)
CIA (1 time)
ECP (1 time)
2019 Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept.
98  psoriasis treated with ultraviolet-B or photochemotherapy
(1 time)
Dermatology
(1 time)
5-S-CD (1 time)
1988 Plasma 5-S-cysteinyldopa as an index of melanogenesis.
99  psoriasis vulgaris before and after treatment with oral photochemotherapy
(1 time)
Dermatology
(1 time)
PMN (2 times)
MNC (1 time)
1980 Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis.
100  psoriasis vulgaris was administered oral 8-methoxypsoralen UVA therapy
(1 time)
Dermatology
(1 time)
LP (1 time)
2003 PUVA-induced lichen planus.